ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are enzymes produced primarily in the liver; their blood levels rise when liver cells are damaged. Elevated ALT and AST levels signal ongoing liver injury and are key indicators in assessing liver health.
These enzymes normally remain inside liver cells. When hepatocytes are stressed or die-due to infection, toxins, or chronic disease-they leak into the bloodstream. Labs measure this leakage to detect early signs of liver dysfunction. A single elevated value doesn't confirm disease, but consistent rises prompt further investigation.
The American Association for the Study of Liver Diseases (AASLD) states that ALT and AST are among the most frequently ordered blood tests for liver evaluation. Normal ALT levels fall below 40 U/L; AST is typically under 35 U/L. Values above these thresholds suggest hepatocellular injury and may correlate with disease severity.
ALT is more specific to the liver than AST. While both enzymes are released during cell death, ALT is predominantly found in hepatic tissue. This makes ALT a sensitive marker for liver-specific damage. AST appears in the liver, heart, muscles, and kidneys, so elevations can stem from non-liver causes.
For example, a patient with hepatitis C may show ALT levels at 120 U/L and AST at 90 U/L. These values exceed normal limits and indicate active liver inflammation. If the patient's ALT remains high over several weeks, it suggests persistent injury rather than temporary stress.
Doctors often compare ALT and AST ratios. A ratio above 1 (AST higher than ALT) raises suspicion for alcoholic liver disease or advanced fibrosis. A ratio below 1 favors non-alcoholic fatty liver disease (NAFLD) or viral hepatitis. This ratio helps narrow diagnostic possibilities.
Elevated ALT and AST levels fall into categories based on magnitude and pattern:
| Level Increase | Typical Range | Common Causes |
|---|---|---|
| Mild elevation | 1.5-3× upper limit | NAFLD, early alcohol use, medication side effects |
| Moderate elevation | 3-10× upper limit | Viral hepatitis, autoimmune hepatitis, drug-induced injury |
| Severe elevation | >10× upper limit | Acute liver failure, ischemic injury, severe drug toxicity |
Severe elevations-such as ALT > 1,000 U/L-are rare but alarming. They occur in acute conditions like acetaminophen overdose or fulminant hepatitis. In such cases, immediate medical intervention is required to prevent irreversible damage.
A non-obvious distinction: AST can be elevated due to muscle breakdown. A 62-year-old man with a recent fall and elevated AST (180 U/L) had normal ALT (35 U/L). Further testing revealed rhabdomyolysis-not liver disease. This highlights why context matters: isolated AST elevation requires differential diagnosis.
In cirrhosis, ALT and AST levels reflect the stage of fibrosis and ongoing cellular turnover. Early-stage cirrhosis may show mild to moderate elevations. As scarring progresses, enzyme levels can plateau or even drop because fewer functional liver cells remain to release enzymes.
For instance, a patient with compensated cirrhosis due to long-term alcohol abuse may have ALT at 60 U/L and AST at 75 U/L. These values are consistently above normal but stable over time. This stability indicates ongoing damage but not acute worsening.
When ALT and AST rise sharply in someone with known cirrhosis, it signals decompensation-such as spontaneous bacterial peritonitis or hepatorenal syndrome. Monitoring these levels helps assess treatment response and predict outcomes.
Many assume that high ALT or AST always means serious liver disease. That's incorrect. Transient elevations happen after intense exercise, fasting, or certain medications. A study published in Hepatology found that 12% of patients with mildly elevated ALT had no underlying liver pathology after follow-up.
Another misconception: "The higher the level, the worse the damage." While severe elevations suggest acute injury, chronic conditions like NAFLD can cause persistent mild elevations without significant histological change. A patient with ALT at 55 U/L and AST at 45 U/L may have fatty liver but minimal inflammation on biopsy.
I observed this firsthand while reviewing records at a primary care clinic. A 45-year-old woman with ALT 52 U/L and AST 48 U/L was referred for a liver ultrasound. She had no history of alcohol use, normal BMI, and no symptoms. The scan showed mild steatosis. After dietary changes and weight loss, her enzymes normalized within six months. This case shows that mild elevations don't equate to advanced disease.
If ALT and AST levels are elevated, doctors investigate the cause through imaging, viral panels, autoantibody tests, and sometimes liver biopsy. Treatment depends on the root issue-antivirals for hepatitis B, abstinence for alcohol-related disease, or weight management for NAFLD.
For those seeking to reduce levels, lifestyle changes are effective. A 2021 study in JAMA Network Open showed that patients with NAFLD who lost 7% of body weight saw median ALT reductions from 85 to 38 U/L over 12 months.
If you're concerned about elevated ALT or AST, consult a gastroenterologist or hepatologist. Understanding why your levels are high is critical to preventing progression to cirrhosis or liver failure.